Screener
Amneal Pharmaceuticals, Inc. AMRX Specialty — Cost of Goods Sold
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-K, filed February 27, 2026.
- Filed
- Feb 26, 2026, 7:00 PM EST
- Fiscal year
- FY2025
- Accession
- 0001723128-26-000011
| Line item | Years Ended December 31, 2025 | Years Ended December 31, 2024 | Years Ended December 31, 2023 |
|---|---|---|---|
| Net revenue | $3,018,760 | $2,793,957 | $2,393,607 |
| Cost of goods sold | 1,905,452 | 1,773,519 | 1,573,042 |
| Gross profit | 1,113,308 | 1,020,438 | 820,565 |
| Selling, general and administrative | 526,827 | 476,436 | 429,675 |
| Research and development | 186,175 | 190,714 | 163,950 |
| In-process research and development impairment charges | — | — | 30,800 |
| Intellectual property legal development expenses | 7,632 | 5,845 | 3,828 |
| Restructuring and other charges | 4,208 | 2,355 | 1,749 |
Item 16. Form 10-K Summary
FAQ
- What is Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold?
- Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — cost of goods sold of $61.48M in Q4 2025.
- How has Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold increased by 21.2% year-over-year, from $50.71M to $61.48M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold has grown at a 6.2% compound annual growth rate (CAGR), from $193.56M to $245.92M.
- What does specialty — cost of goods sold mean?
- Includes all direct costs associated with the manufacturing, procurement, and distribution of specialty pharmaceutical products. This metric is a critical component in determining the segment's gross margin and overall production efficiency. Monitoring this helps identify trends in supply chain costs, raw material pricing, and manufacturing scalability.
Ask your AI about Amneal Pharmaceuticals, Inc.'s specialty — cost of goods sold.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude